Clinical Trial

Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated November 12, 2024 (before its estimated July 27, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the trail is to determine whether DCB is superior to conventional balloon in treating cerebral atherosclerotic stenosis
Trial Details
NCT Number NCT06683118
Lead Sponsor MicroPort NeuroTech Co., Ltd.
Conditions Cerebral Atherosclerotic Stenosis
Enrollment 212 participants
Start Date 2024-05-27
Primary Completion 2025-07-27 (estimated)
Study Completion 2026-07-27 (estimated)
Updated on ClinicalTrials.gov 2024-11-12